§ BIOTECHNOLOGY
USD · BiotechnologyHRTX
HERON THERAPEUTICS INC
USDSector · BiotechnologyBeta · 1.67
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
84 increased/new, 43 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/B | 16.63 | EPS (TTM) | -0.19 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Rubric Capital Management LP | 30.0M | 0.3% | ±0% |
| Clearline Capital LP | 12.2M | 0.5% | ±0% |
| BlackRock, Inc. | 10.1M | 0.0% | −1% |
| ORBIMED ADVISORS LLC | 9.8M | 0.2% | n/a |
| Velan Capital Investment Management LP | 8.8M | 4.4% | ±0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 7.8M | n/a | n/a |
◇ AC INTELLIGENCE
Top institutional owners for HRTX as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER10.9% · 0 holders
OTHER66.2% · 124 holders
PASSIVE / INDEX8.6% · 9 holders
DEALER / BANK5.2% · 17 holders
TACTICAL / MACRO4.5% · 2 holders
INCOME / DEFENSIVE1.4% · 5 holders
SYSTEMATIC / QUANT1.4% · 4 holders
ACTIVIST1.4% · 1 holder
QUALITY / COMPOUNDER0.4% · 6 holders
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for HRTX in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention HRTX yet.